Fair 37°
Tag:

Novavax

News
COVID-19: New Data Reveals How Many Americans Have Gotten Updated Vaccine Shots COVID-19: New Data Reveals How Many Americans Have Gotten Updated Vaccine Shots
Covid-19: New Data Reveals How Many Americans Have Gotten Updated Vaccine Shots New data is shedding light on how many Americans have received a dose of the new COVID-19 booster shot for 2023-24. The updated vaccine has now been available for about a month and a half. More than 1,200 people are dying of COVID each week in the United States  four years after the pandemic started, the CDC says. The Centers for Disease Control and Prevention (CDC) recommended the newest vaccine targeting Omicron subvariants being provided by both Pfizer/BioNTech and Moderna for everyone 6 months of age and older. Another updated vaccine, this one from Novavax, b…

SHARE

by Joe Lombardi
News
COVID-19: Here's How Many Americans Have Gotten Updated Vaccine Compared To Last Year's Booster COVID-19: Here's How Many Americans Have Gotten Updated Vaccine Compared To Last Year's Booster
Covid-19: Here's How Many Americans Have Gotten Updated Vaccine Compared To Last Year's Booster More than seven million Americans have received a dose of the newly released COVID-19 booster shot for 2023-24, according to federal authorities. In mid-September, the Centers for Disease Control and Prevention (CDC) recommended the newest vaccine targeting Omicron subvariants being provided by both Pfizer/BioNTech and Moderna for everyone 6 months of age and older. Another updated vaccine, this one from Novavax, became available this month and is recommended for those aged 12 and over.  The rollout of this year's booster was marked early on by some distribution of…

SHARE

by Joe Lombardi
News
COVID-19: New US-Made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators COVID-19: New US-Made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators
Covid-19: New Us-made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators An American biotech company announced that it has concluded the latest phase of clinical trials for its COVID-19 vaccine, which has proven to be highly effective. Novavax announced on Monday, June 14 that its vaccine has an overall efficacy rate of 90.4 percent in a Phase 3 trial that took place across the United States and Mexico. The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute. Additional analysis of the trial is ongoing, according to the company, and will be submitted to peer-reviewed journals for publication. 
The company said that the vacc…

SHARE

by Zak Failla
News
COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine
Covid-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine Some relief may be on the way for the millions of people awaiting their turn to receive the COVID-19 vaccine. Johnson & Johnson has been developing a single-dose vaccine for COVID-19, which has an efficacy rate of approximately 72 percent, potentially bringing another provider into the mix as vaccines for the virus have become a valuable and scarce commodity. If it is ultimately approved by federal health officials, the Johnson & Johnson vaccine would join Pfizer and Moderna on the market, both of which require two doses administered approximately three weeks apart. However, the ef…

SHARE

by Zak Failla